Status:

COMPLETED

Glucose in Dialysis Water in Non-diabetics

Lead Sponsor:

Regional Hospital Holstebro

Conditions:

Renal Failure, Chronic

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purposes are 1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensi...

Detailed Description

Measurement of hormones and blood pressure during dialysis treatment.

Eligibility Criteria

Inclusion

  • Age \> 18 years,
  • Both men and women,
  • Dialysis treatment for at least three months

Exclusion

  • Heart failure,
  • Chronic liver disease,
  • Diabetes mellitus,
  • Malignant disease,
  • Nephrotic syndrome,
  • Lack of compliance, 7 Unwillingness to participate

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00439023

Start Date

May 1 2006

End Date

May 1 2007

Last Update

September 15 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Holstebro Hospital

Holstebro, Denmark, 7500